I have argued for a while that the US should just give $50B to the first company that can get a vaccine approved; even the 2nd, 3rd and 4th place finisher should get multiple billions. While I don’t like government spending generally, this is clearly a case where pinching pennies makes no sense: in the spring we were losing $trillions of dollars globally. If we could take a month off the time (much less the years usually taken) to develop a vaccine, it would be a great financial tradeoff, not to mention the lives that could be saved. As I was just covering externalities in my Essentials of Economics class, this video popped up in my email, which I plan on sharing tomorrow in class. It’s so good I wanted to share with you! So you get a rare mid-day Berean update.